TFEB
自噬
炎症
癌症研究
医学
药理学
糖尿病肾病
转录因子
化学
PI3K/AKT/mTOR通路
肾
疾病
细胞生物学
氯喹
作用机理
袋3
肾脏疾病
足细胞
蛋白磷酸酶2
磷酸酶
肾脏疾病
糖尿病
生物
促炎细胞因子
内分泌学
作者
Zhishen Xie,Mengmeng Wang,Qingqing Song,Xuan Su,Jenny Jie Chen,Jiangyan Xu,Zhenqiang Zhang,Tongxiang Liu,Xiaowei Zhang,Gai Gao
出处
期刊:ACS omega
[American Chemical Society]
日期:2025-07-18
卷期号:10 (46): 55252-55264
标识
DOI:10.1021/acsomega.5c00038
摘要
High Resolution Image Download MS PowerPoint Slide Diabetic kidney disease (DKD) is widely recognized as the primary cause of end-stage renal disease (ESRD). Activating autophagy is considered a key strategy to improve DKD. Here, through luciferase reporter gene screening of several sesquiterpenoids, it was found that germacrone (GER) significantly activated the transcription factor EB (TFEB), and its effect on DKD and the underlying molecular mechanism was investigated. GER significantly improved renal function impairment and alleviated renal pathological damage. GER inhibited NLR family pyrin domain containing 3 (NLRP3)-mediated inflammatory responses both in vitro and in vivo . Mechanistically, GER activated TFEB to promote autophagy and clear NLRP3 inflammasomes, and the GER-mediated degradation of NLRP3 was reversed by the autophagy inhibitor chloroquine (CQ). Additionally, GER did not affect the expression of TFEB protein but increased its expression in the nucleus. This effect was attributed to the dephosphorylation of p-TFEB (S122) protein caused by the activation of protein phosphatase 2A (PP2A) by GER. This result was further confirmed by supplementing with the PP2A inhibitor okadaic acid (OA). Docking results indicated a stable binding between GER and PP2A. These findings highlighted GER as a potential intervention for treating DKD and clarified the underlying mechanism through which it functions by regulating the PP2A-TFEB pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI